StephenRandolphZukinMD

PubMed

• 6 citations
  Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia.
  Daniel H. Wolf, David Zheng, Christian G. Kohler, Bruce I. Turetsky, Kosha Ruparel, Theodore D. Satterthwaite, Mark A. Elliott, Mary E. March, Alan J. Cross, Mark A. S...> ;Molecular Psychiatry. 2021 Oct 20
• 61 citations
  AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
  Robert E. Litman, Mark A. Smith, James J. Doherty, Alan J. Cross, Shane Raines, Lev Gertsik, Stephen R. Zukin> ;Schizophrenia Research. 2014 Apr 1
• 22 citations
  Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.
  Eduard Vieta, Suresh Durgam, Kaifeng Lu, Adam Ruth, Marc Debelle, S. Zukin> ;European Neuropsychopharmacology. 2015 Nov 1
• 10 citations
  Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibi...
  Laishun Chen, William M. Greenberg, Carl Gommoll, Joann O’Connor, S. Zukin, Antonia Periclou, Parviz Ghahramani> ;Clinical Therapeutics. 2015 Sep 1
• 12 citations
  A Novel Once-Daily Fixed-Dose Combination of Memantine Extended Release and Donepezil for the Treatment of Moderate to Severe Alzheimer’s Disease: Two Phase I Studies ...
  Ramesh Boinpally, Laishun Chen, S. Zukin, Natalie McClure, Robert K. Hofbauer, Antonia Periclou> ;Clinical Drug Investigation. 2015 May 28
• 222 citations
  Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
  Daniel C. Javitt, Stephen R. Zukin, Uriel Heresco-Levy, Daniel Umbricht> ;Schizophrenia Bulletin. 2012 Sep 1
• 11 citations
  P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients
  Bruce I. Turetsky, Gersham Dent, Judith Jaeger, Stephen R. Zukin> ;Psychopharmacology. 2012 May 1
• 30 citations
  A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries
  Steven M. Silverstein, Judith Jaeger, Anne Marie Donovan-Lepore, Sandra Wilkniss, Adam Savitz, Igor Malinovsky, Danielle Hawthorne, Shane Raines, Sarah J. Carson, Step...> ;Journal of Clinical and Experimental Neuropsychology. 2010 May 7
• 220 citations
  Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving.
  Dean F. Wong, Hiroto Kuwabara, David J. Schretlen, Katherine R. Bonson, Yun Zhou, Ayon Nandi, James Robert Brašić, Alane S. Kimes, Marika Maris, Anil Kumar, Carlo Cont...> ;Neuropsychopharmacology. 2006 Sep 13
• 124 citations
  Adjunctive high-dose glycine in the treatment of schizophrenia.
  Daniel C. Javitt, Gail Silipo, Angel Cienfuegos, Anne Marie Shelley, Nigel Bark, Mohan Park, Jean-Pierre Lindenmayer, Ray Suckow, Stephen R. Zukin> ;The International Journal of Neuropsychopharmacology. 2001 Dec 1
• 29 citations
  Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence re...
  Steven Sparenborg, Frank Vocci, Stephen Zukin> ;Drug and Alcohol Dependence. 1997 Dec 15
• 65 citations
  Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial
  Eduardo A. Leiderman, Ilana Zylberman, Stephen R. Zukin, Thomas B. Cooper, Daniel C. Javitt> ;Biological Psychiatry. 1996 Feb 1
• 8 citations
  Pharmacological augmentation of NMDA receptor function for treatment of schizophrenia.
  Ilana Zylberman, Daniel C. Javitt, Stephen R. Zukin> ;Annals of the New York Academy of Sciences. 1995 May 1
• 264 citations
  Amelioration of negative symptoms in Schizophrenia by glycine
  Daniel C. Javitt, Ilana Zylberman, Stephen R. Zukin, Uriel Heresco-Levy, Jean-Pierre Lindenmayer> ;The American Journal of Psychiatry. 1994 Aug 1
• 8 citations
  Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex.
  Daniel C. Javitt, M J Frusciante, Stephen R. Zukin> ;The Journal of Pharmacology and Experimental Therapeutics. 1994 Aug 1
• 6 citations
  Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse research.
  Zukin, D. C. Javitt> ;NIDA Research Monograph. 1993 Jan 1
• 3 citations
  High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
  R Haring, D E Pellegrini-Giampietro, Stephen R. Zukin, R S Zukin, M A Scheideler> ;Molecular Pharmacology. 1991 Nov 1
• 11 citations
  Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
  Ilana Zylberman Nussenzveig, Ratna Sircar, Ma-Li Wong, Mark J. Frusciante, Daniel C. Javitt, Stephen R. Zukin> ;Brain Research. 1991 Oct 11
• 2305 citations
  Recent advances in the phencyclidine model of schizophrenia.
  Daniel C. Javitt, Stephen R. Zukin> ;The American Journal of Psychiatry. 1991 Oct 1
• 13 citations
  Kinetic mechanisms of glycine requirement for N-methyl-D-aspartate channel activation.
  Ratna Sircar, Stephen R. Zukin> ;Brain Research. 1991 Aug 16
• Modulation of phencyclidine receptors by excitatory amino acid receptor ligands.
  Javitt, D. C., Zukin, S. R.> ;Psychopharmacol Bull. 1988
• 17 citations
  Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
  Daniel C. Javitt, Mark J. Frusciante, Stephen R. Zukin> ;Molecular Pharmacology. 1990 May 1
• 5 citations
  Photoaffinity labeling and binding studies reveal the existence of two types of phencyclidine receptors in the NCB-20 cell line
  Rachel Haring, R. Suzanne Zukin, Stephen R. Zukin> ;Neuroscience Letters. 1990 Apr 20
• 58 citations
  The role of excitatory amino acids in neuropsychiatric illness.
  D. C. Javitt, Stephen R. Zukin> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 1990 Jan 1
• 15 citations
  Glycine reverses 7-chlorokynurenic acid-induced inhibition of [3H]MK-801 binding
  Ratna Sircar, Mark J. Frusciante, Daniel C. Javiet, Stephen R. Zukin> ;Brain Research. 1989 Dec 18
• Join now to see all